Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

BioDelivery Sciences’ longtime president, CEO to retire
BioDelivery Sciences’ longtime president, CEO to retire
RALEIGH, N.
Teva intros generic Axiron in the U.S.
Teva intros generic Axiron in the U.S.
JERUSALEM — Teva late last week announced the launch of generic Axiron (testosterone) topical solution CIII, 30-mg-1.
As generics savings increase, FDA looks to spark competition
As generics savings increase, FDA looks to spark competition
Generic medications made up 89% of dispensed U.
Stada says no larger deals on cards over next 2-3 years
Stada says no larger deals on cards over next 2-3 years
FRANKFURT (Reuters) - Stada's (STAGn.
Topas Therapeutics lands option deal with Eli Lilly
Topas Therapeutics lands option deal with Eli Lilly
Evotec's immunology spin-out Topas Therapeutics has inked a multi-year R&D collaboration with pharma major Eli Lilly.
Johnson & Johnson hit with $417M verdict as talcum powder liability losses mount
Johnson & Johnson hit with $417M verdict as talcum powder liability losses mount
Johnson & Johnson has lost yet another talcum powder lawsuit, this time being hit with a $417 million verdict—more than the total awards in the four cases it has already lost.
Bidders line up for Teva's women's health unit in potential $2B sale
Bidders line up for Teva's women's health unit in potential $2B sale
Teva is working to sell off its women’s health unit to churn up cash and pay down debt, and it may have some takers.
Ocrevus approved for treatment of relapsing-remitting MS
Ocrevus approved for treatment of relapsing-remitting MS
Health Canada has approved Hoffman-La Roche’s Ocrevus for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS).
Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times
Drugmaker Hikma's U.S. unit raises medicine prices: Financial Times
NEW YORK (Reuters) - Hikma Pharmaceuticals Plc's U.
Buyout firms get German generics group Stada at second try
Buyout firms get German generics group Stada at second try
FRANKFURT (Reuters) - Bain Capital and Cinven have won control of Germany's Stada (STAGn.
Samsung Bioepis teams up with Takeda to develop original biotech drugs
Samsung Bioepis teams up with Takeda to develop original biotech drugs
SEOUL (Reuters) - Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business sc...
Johnson & Johnson announces partnership with CSIR-IMTECH to develop innovative new tuberculosis treatments
Johnson & Johnson announces partnership with CSIR-IMTECH to develop innovative new tuberculosis treatments
New Delhi, August 18, 2017.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand